Target cell frequency is a genetically determined risk factor in radiation leukaemogenesis

British Journal of Radiology

Volumn 80, Issue SPEC. ISS. 1, 2007, Pages

  Jawad, M ^a   Giotopoulos, G ^a   Cole, C ^a   Plumb, Mark ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PRISTANE;

ACUTE GRANULOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER SUSCEPTIBILITY; CELL COUNT; CELL MATURATION; CELL TRANSFORMATION; CONFERENCE PAPER; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GENE TARGETING; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOME; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; LEUKEMOGENESIS; MOUSE; NONHUMAN; PLASMACYTOMA; QUANTITATIVE TRAIT LOCUS; RADIATION DOSE; RADIATION EXPOSURE; TARGET CELL; THYMUS LYMPHOMA;

ACUTE DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; GENETIC PREDISPOSITION TO DISEASE; LEUKEMIA, MYELOID; LEUKEMIA, RADIATION-INDUCED; LYMPHOMA; MICE; QUANTITATIVE TRAIT LOCI; RISK FACTORS;

EID: 34948867641     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/99530445     Document Type: Conference Paper

References (60)

1. Leone G, Mele L, Pulsoni A, Equitani F, Pagano L. The incidence of secondary leukaemias. Haematologica 1999;84: 937-45.
2. Little MP. Risks associated with ionizing radiation. Br Med Bull 2003;68:259-75.
3. Pierce DA, Shimizu Y, Preston DL, Vaeth M, Mabuchi K. Studies of the mortality of atomic bomb survivors. Report 12, Part I. Cancer: 1950-1990. Radiat Res 1996;146:1-27.
4. Preston DL, Shimizu Y, Pierce DA, Suyama A, Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat Res 2003;160:381-407.
5. Warner JK, Wang JC, Hope KJ, Jin L, Dick JE. Concepts of human leukemic development. Oncogene 2004;23:7164-77.
6. Van Leeuwen FE. Risk of acute myelogenous leukaemia and myelodysplasia following cancer treatment. Baillere's Clinical Haematol 1996;9:57-85.
7. Taramelli R, Acquati F. The human genome project and the discovery of genetic determinants of cancer susceptibility. Eur J Cancer 2004;40:2537-43.
8. Allan JM, WOd CP, Rollinson S, Willett EV, Moorman AV, Dovey GJ, et al. Polymorphism in glutathione S-transferase Pl is associated with susceptibility to chemotherapy-induced leukaemia. Proc Natl Acad Sci USA 2001;98:11592-7.
9. Felix CA, Walker AH, Lange BJ, Williams TM, Winick NJ, Cheung NV, et al. Association of CYP3A4 genotype with treatment-related leukaemia. Proc Natl Acad Sci USA 1998;95:13176-81.
10. 609C-T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukaemia. Blood 1999;94:803-7.
11. Lebailly P, Willett EV, Moorman AV, Roman E, Carwright R, Morgan GJ, et al. Genetic polymorphisms in microsomal epoxide hydrolase and susceptibility to adult acute myeloid leukaemia with defined cytogenetic abnormalities. Br J Haematol 2002;116:587-94.
12. Sasai Y, Horiike S, Misawa S, Kaneko H, Kobayashi M, Fujii H, et al. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leuk Res 1999;23:975-81.
13. Seedhouse C, Bainton R, Lewis M, Harding A, Russell N, Das-Gupta E. The genotype distribution of the XRCC1 gene indicates a role for base excision repair in the development of therapy-related acute myelobastic leukemia. Blood 2002;100:3761-6.
14. Seedhouse C, Faulner R, Ashraf N, Das-Gupta E, Russell N. Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukaemia. Clin Cancer Res 2004;10:2675-80.
15. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005;437:1299-320.
16. Major IR. Induction of myeloid leukaemia by whole-body single exposure of CBA male mice to X-rays. Br J Cancer 1979;40:903-13.
17. Upton AC, Wolff FF, Furth J, Kimball AW. A comparison of the induction of myeloid and lymphoid leukaemias in X-irradiated RF mice. Cancer Res 1958;18:842-8.
18. Cook WD, McCaw BJ, Herring C, John, DL, Foote SJ, Nutt SL, et al. PU.1 is a suppressor of myeloid leukaemia, inactivated by gene deletion and mutation of its DNA-binding domain. Blood 2004;104:3437-44.
19. Boulton E, Cleary H, Papworth D, Plumb M. Susceptibility to radiation-induced leukaemia/lymphoma is genetically separable from sensitivity to radiation-induced genomic instability. Int J Radiat Biol 2001;77:21-9.
20. Wright EG, Lorimore SA. Radiation-induced murine leukaemia: a model for acute myeloid leukaemia. In: Abraham NG, Konwalinka G, Sachs L, Wiedeman CJ, editors. Molecular biology of haematopoiesis. UK: Intercept Ltd, 1989:607-18.
21. Cleary H, Boulton E, Plumb M. Allelic loss on chromosome 4 (Lyr2/TLSR5) is associated with myeloid, B-lymphomyeloid and lymphoid (B & T) mouse radiation-induced leukaemias. Blood 2001;98:1549-54.
22. Pedersen-Bjergaard J, Pedersen M, Roulston D, Philip P. Different genetic pathways in leukaemogenesis for patients presenting with therapy-related myelodysplasia and therapy-related acute myeloid leukaemia. Blood 1995;86:3542-52.
23. Hayata I, Seki M, Yoshida K, Hirashima K, Sado T, Yamagiwa J, et al. Chromosomal aberrations observed in 52 mouse myeloid leukaemias. Cancer Res 1983;43:367-73.
24. Boulton E, Cole C, Knight A, Cleary H, Snowden R, Plumb M. Low-penetrance genetic susceptibility and resistance loci implicated in the relative risk for radiation-induced acute myeloid leukaemia in mice. Blood 2003;101:2349-54.
25. Kaplan HS, Brown MB. A quantitative dose-response study of lymphoid-tumour development in irradiated C57 Black mice. J Natl Cancer Inst 1952;13:185-92.
26. Rongy AM, Humblet C, Lelevre P, Greimers R, Defresne MP, Boniver J. Abnormal thymocyte subpopulations in split dose irradiated C57BL/Ka mice before the onset of lymphomas. Effects of bone marrow grafting. Thymus 1990;16:7-27.
27. Sen-Majumdar A, Guidos C, Kina T, Lieberman M, Weissman IL. Characterization of preneoplastic thymocytes and of their neoplastic progression in irradiated C57BL/Ka mice. J Immunol 1994;153:1581-92.
28. h immunoglobulin gene rearrangements. Proc Natl Acad Sci USA 1983;80:7433-6.
29. Kubo E, Muto M, Sado T, Takeshita S, Shimizu T, Yamagishi H. Novel TCR gene rearrangements and expression in radiation-induced thymic lymphomas. J Radiat Res 1992;33:227-42.
30. Vasmel WLE, Radaszkiewicz T, Miltenburg AM, Zjilstra M, Melief CJM. Refinement and precision in the classification of murine lymphomas by genotyping with immunoglobulin and T cell receptor probes. Leukemia 1987;1:155-62.
31. Boulton E, Cleary H, Plumb M. Myeloid, B and T lymphoid and mixed lineage thymic lymphomas in the irradiated mouse. Carcinogenesis 2002;23:1079-85.
32. Shimizu T, Muto M, Kubo E, Sado T, Yamagishi H. Multiple pre-neoplastic events and clonal selection of radiation induced thymic lymphomas shown by TCR gene rearrangements. Leuk Res 1993;17:959-65.
33. Santos J, Montagutelli X, Acevedo A, Lopez P, Vaquero C, Fernandez M, et al. A new locus for resistance to gamma-radiation-induced thymic lymphoma identified using interspecific consomic and inter-specific recombinant congenic strains of mice. Oncogene 2002;21:6680-3.
34. Saito Y, Ochiai Y, Kodama Y, Tamura Y, Togashi T, Kosugi-Okano H, et al. Genetic loci controlling susceptibility to γ-ray-induced thymic lymphoma . Oncogene 2001;20:5243-7.
35. Mori N, Okumoto M, Yamate J. A susceptibility locus for radiation lymphomagenesis on mouse chromosome 16. J Radiat Res 2000;41:367-72.
36. Jhappan C, Morse HC, Felischmann RD, Gottesman MM, Merlino G. DNA-PKcs: a T-cell tumour suppressor encoded at the mouse scid locus. Nature Genet 1997;4:483-6.
37. Yu Y, Okayasu R, Wel MM, Silver A, McCarthy M, Zabriskie R, et al. Elevated breast cancer risk in irradiated BALB/c mice associates with unique functional polymorphism of the Prkdc (DNA-PKcs) gene. Cancer Res 2001;61:1820-4.
38. Okayasu R, Suetomi K, Yu Y, Silver A, Bedford JS, Cox R, et al. A deficiency in DNA repair and DNA-PKcs expression in the radiosensitive BALB/c mouse. Cancer Res 2000;60:4342-5.
39. Yamada Y, Shisa H, Matsushiro H, Kamoto T, Kobayashi Y, Kawari A, et al. T lymphomagenesis is determined by a dominant host gene Thymic lymphoma susceptible mouse-1 (TLSM-1) in mouse models. J Exp Med 1994;180:2155-62.
40. Yamada Y, Matsushiro H, Ogawa MS, Okamoto K, Nakakuki Y, Toyokuni S, et al. Genetic predisposition to pre-B lymphomas in SL/Kh strain mice. Cancer Res 1994;54:403-7.
41. Mock BA, Krall MM, Dosik JK. Genetic mapping of tumour susceptibility genes involved in mouse plasmacytomagenesis. Proc Natl Acad Sci USA 1993;90:9499-503.
42. Zhang S, Ramsay ES, Mock BA. Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytomas susceptibility locus, Pctr1. Proc Natl Acad Sci USA 1998;95:2429-34.
43. Zhang SL, DuBois W, Ramsay ES, Bliskovski V, Morse HC, Taddesse-Heath L, et al. Efficiency alleles of the Petri modifier locus for plasmacytoma susceptibility. Mol Cell Biol 2001;21:310-18.
44. Morrison SJ, Qian D, Jerabek L, Thiel BA, Park I-K, Ford PS, et al. A genetic determinant that specifically regulates the frequency of hematopoietic stem cells. J Immunol 2002;68:635-42.
45. Muller-Sieburg CE, Riblet R. Generic control of the frequency of haemopoietic stem cells in mice: mapping a candidate locus to chromosome 1. J Exp Med 1996;183: 1141-50.
46. Geiger H, True JM, de Haan G, Van Zant G. Age- and stage-specific regulation patterns in the hematopoietic stem cell hierarchy. Blood 2001;98:2966-72.
47. De Haan G, Nijhof W, Van Zant G. Mouse strain-dependent changes in frequency and proliferation of hematopoietic stem cells during aging: correlation between lifespan and cycling activity. Blood 1997;89:1543-50.
48. De Haan G, Van Zant G. Dynamic changes in mouse hematopoietic stem cell numbers during aging. Blood 1999;93:3294-301.
49. De Haan G, Ausema A, Wilkins M, Molineux G, Dontje B. Efficient mobilization of haemopoietic progenitors after a single injection of pegylated recombinant human granulocyte colony-stimulating factor in mouse strains with distinct marrow-cell pool sizes. Br J Haematol 2000;110:638-46.
50. Henckaerts E, Geiger H, Langer JC, Rebollo P, van Zant G, Snoeck H-W. Genetically determined variation in the number of phenotypically defined haemopoietic progenitor and stem cells and in their response to early-acting cytokines. Blood 2002;99:3947-54.
51. Chen J, Harrison DE. Quantitative trait loci regulating lymphocyte proportions in mouse peripheral blood. Blood 2002;99:562-6.
52. Thompson GA. A review of theoretical aspects of HLA and disease associations. Theor Popul Biol 1987;20:168-208.
53. Papadaki HA, Gibson FM, Gordon-Smith EC, Marsh JCW, Eliopoulos GD. Assessment of bone marrow stem cell reserve and function and stromal cell function in patients with severe congenital neutropenia. Eur J Haematol 2001;67:245-51.
54. Humpe A, Riggert J, Vehmeyer K, Troff C, Hiddemann W, Kohler M, et al. Comparison of CD34+ cell numbers and colony growth before and after cryopreservation of peripheral blood progenitor and stem cell harvests: influence of prior chemotherapy. Transfusion 1997;37:1050-7.
55. Ferrero D, Cherasco C, Ortolano B, Giaretta F, Bruno B. In vitro growth and quantification of early (CD33-/CD38-) myeloid progenitor cells: stem cell factor requirement and effects of previous chemotherapy. Haematologica 1999;84:390-6.
56. Marley SB, Lewis JL, Davidson RJ, Roberts AG, Dokal I, Goldmamn JM, et al. Evidence for continuous decline in haemopoietic cell function from birth: application to evaluating bone marrow failure in children. Br J Haematol 1999;106:162-6.
57. Chapple P, Prince HM, Quinn M, Bertoncello I, Juneja S, Wolf M, et al. Peripheral blood CD34+ cell count reliably predicts autograft yield. Bone Marrow Transplant 1998;22: 125-30.
58. Kroger N, Renges H, Kruger W, Gutensohn K, Loliger C, Carrero I, et al. A randomised comparison of once versus twice daily recombinant human granulocyte colony-stimulating factor (filgrastim) for stem cell mobilization in healthy donors for allogenic transplantation. Br J Haematol 2000;111:761-5.
59. Roberts AW, Foote S, Alexander WS, Scott C, Robb L, Metcalf D. Genetic influences determining progenitor cell mobilization and leukocytosis induced by granulocyte colony-stimulating factor. Blood 1997;89:2736-44.
60. Tabilio A, Falzetti F, Giannoni C, Aversa F, Martelli MP, Rossetti M, et al. Stem cell mobilization in normal donors. J Hematother 1997;6:227-34.